Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Show more
Rue Edouard Belin 12, Mont-Saint-Guibert, 1435, Belgium
Market Cap
131M
52 Wk Range
$2.76 - $8.64
Previous Close
$3.00
Open
$2.99
Volume
2,428
Day Range
$2.95 - $3.01
Enterprise Value
124.1M
Cash
48.0M
Avg Qtr Burn
-13.24M
Insider Ownership
37.04%
Institutional Own.
21.52%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|